Clinical Trials Logo

Anaplastic Thyroid Cancer clinical trials

View clinical trials related to Anaplastic Thyroid Cancer.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT01701349 Withdrawn - Clinical trials for Anaplastic Thyroid Cancer

Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer

FACT2
Start date: March 2015
Phase: Phase 3
Study type: Interventional

This is a multicenter, double-blind, placebo-controlled, randomized study of fosbretabulin given with chemotherapy (paclitaxel and carboplatin) compared to placebo given with chemotherapy (paclitaxel and carboplatin) in subjects with anaplastic thyroid cancer (ATC). The primary objective of the study is to determine overall survival. A maximum of 300 subjects will be recruited from approximately 75 multinational sites of which approximately 35 will be located in the United States.